Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Timely detection of a potentially fatal chronic liver disease that one out of four of us have without knowing it.

Project description

Solution for chronic liver disease detection

It is possible for people to unknowingly have a potentially fatal disease, such as chronic liver disease. Diagnostic measures incorporating evidence-based and data-driven solutions are crucial for timely detection. The EU-funded LiverPRO project will receive a resource boost from Women TechEU, encompassing both financial support and targeted coaching. This boost aims to propel LiverPRO towards commercial success while facilitating its entry into the market. Developed by Evido, a health tech company, LiverPRO employs innovative data models to swiftly identify and provide support to individuals at risk of chronic liver disease. This automation solution seamlessly integrates with existing healthcare workflows and systems, resulting in cost savings attributed to optimised patient pathways. Notably, it is specifically tailored for primary care clinicians, enhancing the efficient utilisation of resources.

Objective

Evido is a health tech company that originates from the clinical world and stands on top of more than a decade of extensive clinical research from the elite Center of Liver Research at Odense University Hospital. We are a team of hepatologists, clinical researchers, data geeks, venture builders and healthcare innovators. All sharing a common goal to help people at risk of Chronic Liver Disease by re-inventing diagnostics with evidence-based and data-driven solutions. Our mission is to ensure timely detection and support of at-risk people that unknowingly have a potential fatal disease.

We see the Women TechEU programme as a great opportunity that will front load our commercial traction and accelerate our time to market. Up to this point we have achieved to attract funding to cover our product development cost and regulatory affair. We have achieved to set up international collaborations to mature our data model and test our solution. All key activities to get LiverPRO to market and accelerate our adoption.

To build on this traction and ensure a holistic perspective on our business, we want to broaden our activities and start frontloading our commercial activities already in the beginning of 2023. We see Women TechEU as a brilliant programme to support us in doing exactly this. Women TechEU can give us a resource boost to expand our focus and enable us to pursue commercial traction in parallel to getting LiverPRO to the market. We see a huge value in being part of the mentoring and coaching part of the programme and could really benefit from getting input on roll-out strategy, pricing, sales processes, pilot sales, etc. The combination of both financial support and specific coaching will help us accelerate our commercial traction and build a robust go-to-market strategy.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-CSA - HORIZON Coordination and Support Actions

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-EIE-2022-SCALEUP-02

See all projects funded under this call

Coordinator

EVIDO APS
Net EU contribution
€ 75 000,00
Address
Danneskiold-Samsoes Alle 41
1434 Copenhagen
Denmark
SME
Yes
Region
Danmark Hovedstaden Byen København
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost
No data